VOYA Investment Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Other funds holding ALDX
KCM
VCM
KCM
6CM
VOYA Investment Management's ALDX Position: Q1 2026 in Review
VOYA Investment Management sold out of Aldeyra Therapeutics (ALDX) in Q1 2026, closing a stake of 10,066 shares — an estimated $52.1K sold.
VOYA Investment Management first reported a position in ALDX in Q2 2019 and held it in 19 quarters. The position peaked at $216K in Q2 2021. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.
- VOYA Investment Management reported no remaining Aldeyra Therapeutics position as of Q1 2026 after selling out during the quarter.
- VOYA Investment Management sold 10,066 Aldeyra Therapeutics shares in Q1 2026, an estimated $52.1K.
- VOYA Investment Management first reported a position in Aldeyra Therapeutics in Q2 2019 and held it in 19 quarters.
- VOYA Investment Management's Aldeyra Therapeutics position peaked at $216K in Q2 2021.
- 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.
Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.